No definition available.
Liposarcoma, excluding all cancers (controls excluding all cancers)
C3_LIPOSARCOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
342 |
4. Check minimum number of eventsNone |
342 |
5. Include endpointsNone |
342 |
6. Filter based on genotype QC (FinnGen only) |
342 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Liposarcoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 342 | 135 | 207 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.09 |
| Median age at first event (years) | 62.45 | 59.80 | 64.18 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 216
- Matched controls
- 2159
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
+∞
67.3
61
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
128.0
54.9
57
6
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
54.5
50
*
130
Kela drug reimbursment
Malignant tumour
+∞
54.5
50
*
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
53.4
49
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
45.4
42
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
42.1
39
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
39.8
37
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
31.2
34.0
45
18
H02AB02
ATC
dexamethasone; systemic
52.5
33.1
39
9
JN4BD
NOMESCO Finland
Extensive body CT
16.0
32.3
54
44
A04AA02
ATC
granisetron; systemic, transdermal
120.0
29.5
31
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.4
29.5
145
595
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
320.8
28.5
28
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.5
27.4
51
52
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
307.2
27.4
27
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
+∞
25.5
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.1
24.0
95
290
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
32.6
23.9
31
11
B01AB05
ATC
enoxaparin; parenteral
4.7
23.6
104
353
XX3DW
NOMESCO Finland
Time consuming IT work
12.5
23.4
43
42
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
23.3
22
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
23.3
22
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
134.3
23.1
24
*
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
33.2
22.5
29
10
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
22.3
21
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
89.7
22.2
24
*
B01AB10
ATC
tinzaparin; parenteral
12.7
22.0
40
38
A03FA01
ATC
metoclopramide; systemic, rectal
7.0
22.0
59
110
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
21.2
20
*
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
20.1
19
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.1
19
*
WX402
NOMESCO Finland
General anaesthesia
5.5
19.6
65
157
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.4
19.3
35
33
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
19.0
18
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.1
18.4
89
314
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
18.0
17
*
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
18.0
17
*
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
18.0
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
18.0
17
*
JN4AD
NOMESCO Finland
Body CT examination
10.6
16.9
33
36
R4110
NOMESCO Finland
Physiotherapy
3.9
16.9
89
332
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
16.9
16
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
15.8
15
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
+∞
15.8
15
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
171.9
15.7
16
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.2
15.0
22
12
WF002
NOMESCO Finland
Radical radiotherapy
86.1
14.8
16
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
14.7
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.7
14
*
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
14.7
14
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
14.7
14
*
L03AA02
ATC
filgrastim; parenteral
+∞
14.7
14
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
14.7
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.6
14.2
43
91
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
13.7
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
149.0
13.6
14
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
7.6
13.6
32
48
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.2
12.9
42
96
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.7
12.9
30
44
WX306
NOMESCO Finland
Lumbar epidural anesthesy
8.9
12.8
27
34
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
12.6
12
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
9.3
12.2
25
30
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
11.5
12.1
22
21
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
24.5
11.8
16
7
A04AA01
ATC
ondansetron; systemic, rectal
12.8
11.6
20
17
KAC00
NOMESCO Finland
Nephrectomy
+∞
11.6
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.6
11
*
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
11.6
11
*
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
11.6
11
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
11.6
11
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.2
11.3
25
34
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.9
11.1
25
35
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
19.1
10.9
16
9
JN4CD
NOMESCO Finland
Very extensive body CT
15.3
10.7
17
12
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
115.4
10.5
11
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
115.4
10.5
11
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
115.4
10.5
11
*
Z51.5
ICD-10 Finland
Palliative care
11.5
10.5
19
18
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
10.5
10
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
10.5
10
*
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
10.5
10
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
10.5
10
*
A04AD12
ATC
aprepitant; systemic
+∞
10.5
10
*
N02AA05
ATC
oxycodone; systemic
3.9
10.1
43
128
N02BE01
ATC
paracetamol; systemic, rectal
3.5
10.0
192
1496
S18
ICPC
Laceration/cut
2.6
10.0
109
611
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
12.2
9.7
17
15
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
12.2
9.7
17
15
WZC30
NOMESCO Finland
Teaching
4.3
9.7
37
100
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.4
9.5
19
22
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
22.9
9.5
13
6
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
9.4
9
*
R4120
NOMESCO Finland
Occupational therapy
4.9
9.4
31
72
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.3
8.7
15
13
ZXA05
NOMESCO Finland
Left side
2.6
8.7
77
379
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
17.2
8.7
13
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
8.6
49
183
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
93.6
8.5
9
*
JAH00
NOMESCO Finland
Laparotomy
11.4
8.4
15
14
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
+∞
8.4
8
*
C49.62
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the trunk, unspecified localization liposarcoma
+∞
8.4
8
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
23.1
8.1
11
5
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
13.7
8.0
13
10
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
10.0
7.9
15
16
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.8
7.8
12
8
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
82.8
7.5
8
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
82.8
7.5
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
82.8
7.5
8
*
ZXA00
NOMESCO Finland
Right side
2.4
7.4
74
384
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
7.3
7
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
L02AE02
ATC
leuprorelin; implant, parenteral
23.4
6.7
9
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.5
6.6
12
12
TQW99
NOMESCO Finland
Other minor procedure on skin
6.6
6.6
16
26
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.7
6.6
21
48
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.5
44
182
WW500
NOMESCO Finland
Blood transfusion
8.6
6.4
13
16
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
6.3
6
*
ZZR30
NOMESCO Finland
Flap of muscle
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
6.3
6
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
ZZR00
NOMESCO Finland
Flap of skin
27.6
6.3
8
*
WX320
NOMESCO Finland
Spinalanesthesy
2.4
6.2
57
282
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
225
1151
3.79
30.92
5.9
3.6
—
—
—
0
0
61
143
4.97
25.09
3.3
1.6
3.2
4.8
ug/l
0.36
50
112
138
595
3.21
23.46
3.6
2.0
—
—
—
0
0
189
1122
2.53
15.80
7.4
3.8
34.3
35.9
g/l
3.09
176
1051
223
1433
2.60
15.69
14.7
6.4
4.4
4.3
e9/l
0.23
203
1239
69
251
3.19
14.95
4.4
2.8
—
—
—
0
0
46
143
3.56
12.71
10.5
7.8
24.2
24.8
mmol/l
0.64
46
129
68
269
2.91
12.61
8.8
6.8
118.6
124.3
g/l
1.59
68
262
77
326
2.76
12.57
8.2
6.2
0.2
1.3
mmol/l
1.76
68
246
185
1165
2.28
12.55
8.0
5.0
1.2
1.2
mmol/l
0.84
173
1042
76
321
2.76
12.46
8.4
6.2
14.1
12.1
kpa
2.32
76
308
76
321
2.76
12.46
8.4
6.3
5.2
5.1
kpa
0.65
76
306
195
1262
2.27
12.30
8.6
5.6
1.2
1.2
mmol/l
1.91
164
1100
130
719
2.30
11.90
3.2
2.8
0.6
0.4
e6/l
0.17
100
521
271
2041
2.58
11.68
12.6
5.3
83.4
75.1
u/l
2.24
264
1878
98
493
2.38
11.05
4.8
2.1
2.5
2.4
mmol/l
1.08
83
419
227
1608
2.22
10.89
6.6
4.1
6.9
6.8
mmol/l
0.46
222
1493
46
165
3.07
10.06
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
78
3.97
9.82
2.9
2.5
0.3
0.3
u/ml
0.03
15
41
137
825
2.10
9.74
7.2
2.1
2.4
2.4
mmol/l
0.04
118
679
147
959
1.93
7.97
3.3
2.9
—
—
—
0
0
312
2715
2.70
6.69
24.9
12.3
34.6
23.9
mg/l
5.34
280
2106
52
244
2.33
6.65
9.6
5.5
1.0
1.5
mmol/l
5.18
52
236
126
835
1.81
6.15
3.7
2.7
30.9
31.8
u/l
0.16
120
789
17
44
4.01
6.06
1.3
1.4
—
—
—
0
0
53
261
2.22
6.04
3.6
2.8
211.4
235.5
u/l
1.64
53
242
42
195
2.32
5.50
3.7
1.9
53.9
63.4
ml/min/173m2
0.89
14
79
13
30
4.47
5.34
1.2
1.2
75.6
61.4
pmol/l
0.53
13
30
77
461
1.87
5.11
2.8
2.6
0.9
1.0
e6/l
0.13
41
255
124
867
1.67
4.77
2.4
2.1
61.7
56.5
u/l
0.38
117
799
14
38
3.80
4.69
1.4
1.2
—
—
—
0
0
7
5
14.25
4.59
1.9
1.0
66.1
70.2
nmol/l
—
7
5
97
644
1.71
4.49
2.2
2.1
3.2
3.0
mg/l
0.17
87
545
71
431
1.82
4.47
3.0
2.8
2.1
2.1
e6/l
0.00
36
226
55
310
1.92
4.36
1.7
1.8
—
—
—
0
0
55
312
1.91
4.27
1.7
1.8
—
—
—
0
0
70
434
1.77
4.09
1.9
1.7
—
—
—
0
0
167
1295
1.57
4.03
4.2
3.4
0.0
0.0
estimate
0.00
41
214
167
1297
1.56
3.99
5.3
4.8
0.0
0.0
estimate
0.00
38
213
316
2893
2.21
3.85
27.3
15.0
139.4
139.8
mmol/l
2.15
310
2806
316
2902
2.17
3.67
27.6
15.0
4.0
4.0
mmol/l
0.51
310
2812
290
2591
1.78
3.66
24.9
11.1
77.9
78.4
ml/min/173m2
0.16
258
2087
85
575
1.64
3.59
1.9
1.7
1.4
1.1
mg/l
0.71
68
444
167
1320
1.52
3.55
4.2
3.5
0.0
0.0
estimate
0.00
39
209
8
13
6.27
3.52
2.4
1.4
—
—
—
0
0
96
688
1.55
3.14
4.8
3.6
0.0
0.0
estimate
0.50
38
202
11
34
3.31
3.08
2.2
1.4
—
—
—
0
0
10
29
3.52
3.07
2.3
1.3
—
—
—
0
0
9
21
4.37
3.01
2.2
1.6
—
—
—
0
0
6
9
6.76
2.88
2.0
2.0
—
—
—
0
0
5
6
8.43
2.76
1.2
1.0
—
—
—
0
0
6
10
6.08
2.71
2.8
1.5
—
—
—
0
0
6
10
6.08
2.71
2.8
1.5
—
—
—
0
0
315
2940
1.90
2.70
30.5
14.6
84.3
81.4
umol/l
0.85
315
2940
10
32
3.19
2.66
2.1
1.4
—
—
—
0
0
129
1016
1.43
2.58
4.4
3.6
—
—
—
0
0
6
11
5.53
2.55
1.7
1.7
—
—
—
0
0
78
560
1.51
2.49
3.7
3.9
53.7
453.6
ng/l
3.02
67
457
7
16
4.44
2.48
2.6
1.4
—
—
—
0
0
13
51
2.61
2.47
2.0
1.4
—
—
—
0
0
271
2451
1.51
2.46
27.5
13.7
38.4
40.1
%
2.25
197
1683
57
389
1.56
2.29
24.8
24.6
1.6
1.4
inr
—
8
51
230
2030
1.41
2.27
3.6
4.0
14.8
11.7
mm/h
1.64
208
1867
5
9
5.62
2.22
2.0
1.9
—
—
—
0
0
10
36
2.83
2.22
2.1
1.4
—
—
—
0
0
10
36
2.83
2.22
1.0
1.3
3.2
10.8
u/ml
—
5
17
133
1076
1.39
2.22
2.7
2.6
239.6
127.8
ug/l
1.33
126
988
28
159
1.83
2.21
1.3
1.4
—
—
—
0
0
12
48
2.55
2.21
2.1
1.4
—
—
—
0
0
13
55
2.42
2.15
1.5
1.2
—
—
—
0
0
10
37
2.75
2.12
2.1
1.4
—
—
—
0
0
16
75
2.19
2.12
1.1
1.3
—
—
—
0
0
11
43
2.61
2.11
2.0
1.4
—
—
—
0
0
31
185
1.74
2.09
6.6
6.7
24.8
24.3
mmol/l
0.59
31
172
10
38
2.68
2.02
5.2
2.6
63.2
58.8
%
—
10
38
313
2959
1.68
1.95
15.4
8.8
27.3
26.0
u/l
0.67
302
2843
28
167
1.74
1.91
1.6
1.6
—
—
—
0
0
9
34
2.69
1.88
1.0
1.3
—
3.7
—
0
10
23
130
1.82
1.87
5.3
3.9
23.2
24.5
mmol/l
1.34
23
117
15
73
2.10
1.83
1.5
1.7
—
—
—
0
0
20
109
1.89
1.81
2.3
1.3
3.2
3.9
g/l
2.44
15
72
20
109
1.89
1.81
2.3
1.3
8.0
7.6
g/l
0.27
15
76
20
109
1.89
1.81
2.3
1.3
—
—
—
0
0
34
221
1.60
1.70
7.5
7.2
11.8
10.3
mmol/l
0.51
34
210
12
55
2.22
1.69
1.3
1.3
—
—
—
0
0
320
3059
1.72
1.68
36.7
18.3
130.2
137.9
g/l
12.07
315
2998
7
25
2.84
1.66
1.6
1.4
—
—
—
0
0
111
908
1.33
1.65
3.3
2.9
1843.3
1471.1
ng/l
0.42
99
774
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
39
266
1.53
1.60
4.0
3.3
1.2
1.9
mmol/l
0.77
33
217
8
33
2.46
1.54
1.1
1.1
—
—
—
0
0
17
93
1.87
1.54
2.1
1.7
0.2
1.8
ug/l
1.68
17
82
7
27
2.62
1.52
1.0
1.3
—
—
—
0
0
24
373
0.62
1.49
3.8
4.8
29.3
31.5
%
0.56
15
255
9
38
2.40
1.46
1.0
1.1
—
—
—
0
0
6
22
2.76
1.44
2.7
1.4
—
—
—
0
0
15
83
1.84
1.33
1.8
3.9
—
—
—
0
0
9
43
2.12
1.31
1.2
1.3
—
—
—
0
0
9
43
2.12
1.31
1.2
1.3
—
—
—
0
0
6
24
2.53
1.31
1.0
1.0
—
—
—
0
0
20
312
0.62
1.28
1.4
1.8
1.4
1.6
%
0.74
15
271
91
754
1.28
1.20
2.6
2.5
382.8
9083.3
umol/l
3.82
76
654
62
775
0.76
1.19
1.6
1.7
1.5
1.4
mmol/l
0.57
44
638
11
57
1.96
1.18
1.7
1.5
—
—
—
0
0
11
59
1.89
1.08
1.1
1.1
—
—
—
0
0
6
27
2.24
0.94
2.5
3.7
—
—
—
0
0
12
70
1.74
0.94
1.3
1.3
—
—
—
0
0
268
2801
0.80
0.90
4.1
4.7
4.5
4.5
mmol/l
0.18
243
2596
6
29
2.09
0.89
1.5
1.1
—
—
—
0
0
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
6
30
2.02
0.87
1.5
1.1
—
—
—
0
0
192
1772
1.19
0.85
3.4
3.0
68.1
48.0
u/l
0.86
181
1658
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
217
2037
1.18
0.75
4.0
3.5
14.8
14.9
pmol/l
0.25
194
1850
267
2777
0.82
0.74
4.0
4.7
1.4
1.4
mmol/l
2.07
238
2563
5
25
2.01
0.73
1.8
1.4
—
—
—
0
0
10
60
1.69
0.73
2.3
1.4
8.0
4.6
iu/l
—
5
21
11
68
1.64
0.72
1.2
1.5
—
—
—
0
0
43
347
1.27
0.72
1.5
1.4
—
—
—
0
0
17
118
1.46
0.70
5.8
4.3
1.7
1.6
%
0.28
17
113
5
91
0.54
0.68
1.8
1.8
—
—
—
0
0
10
62
1.63
0.65
1.3
1.2
3.6
3.9
mmol/l
—
10
57
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
13
187
0.68
0.63
4.6
3.7
5.0
5.1
kpa
0.35
13
171
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
6
35
1.73
0.58
1.2
1.5
—
—
—
0
0
8
124
0.64
0.55
6.0
4.2
25.4
25.1
mmol/l
—
8
114
54
463
1.20
0.55
1.2
1.3
39.2
35.1
iu/ml
0.07
17
134
9
60
1.51
0.54
1.3
1.2
—
—
—
0
0
13
180
0.71
0.53
1.5
1.9
—
—
—
0
0
6
40
1.51
0.52
1.2
1.2
—
—
—
0
0
13
93
1.41
0.49
2.5
1.5
—
—
—
0
0
114
1048
1.13
0.48
2.2
2.2
74.4
76.9
nmol/l
0.44
103
915
77
690
1.15
0.47
1.5
1.5
21.7
20.3
nmol/l
0.29
66
584
12
161
0.74
0.42
1.5
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
11
79
1.41
0.41
1.2
1.1
—
—
—
0
0
11
79
1.41
0.41
1.2
1.1
—
—
—
0
0
10
71
1.42
0.39
1.3
1.3
812.1
512.3
mg/l
—
10
66
279
2854
0.88
0.38
4.6
5.3
2.7
2.7
mmol/l
0.20
251
2633
13
99
1.33
0.36
1.4
1.5
3.4
2.7
mg/l
—
7
72
5
79
0.63
0.36
1.2
1.5
—
—
—
0
0
67
610
1.12
0.33
3.8
3.8
1.0
1.0
kg/l
0.91
13
97
270
2761
0.90
0.33
4.7
4.7
6.2
6.0
mmol/l
0.68
240
2517
262
2674
0.91
0.26
3.7
4.2
1.4
1.3
mmol/l
0.84
231
2449
257
2517
1.08
0.24
4.6
4.4
1.8
2.0
mu/l
0.81
229
2289
14
116
1.22
0.22
2.6
1.9
37.9
39.2
u/l
0.09
14
100
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
8.9
—
0
12
123
1179
1.07
0.21
1.9
2.0
94.8
94.5
pmol/l
0.02
69
613
57
611
0.92
0.20
1.7
1.7
150000378.0
7828212.1
pmol/l
0.46
48
511
109
1042
1.07
0.20
4.6
3.8
21.6
24.0
%
0.90
55
500
40
366
1.11
0.20
10.1
7.3
—
—
—
0
0
159
1544
1.06
0.17
2.8
2.7
—
—
—
0
0
12
101
1.19
0.17
2.8
1.6
—
—
—
0
0
14
120
1.17
0.16
1.4
1.3
—
—
—
0
0
52
553
0.93
0.16
1.9
1.8
1162.3
1187.2
nmol/l
0.05
38
432
41
440
0.92
0.15
1.2
1.2
5.4
8.2
u/ml
0.31
14
158
13
112
1.17
0.14
1.1
1.0
—
—
—
0
0
9
106
0.84
0.13
1.4
1.6
—
132.0
—
0
5
118
1146
1.05
0.12
4.1
3.6
45.9
43.0
ng/l
0.09
101
832
17
153
1.12
0.11
1.5
2.2
1.0
1.1
%
0.40
17
153
264
2668
0.95
0.11
5.5
6.2
40.3
40.3
mmol/mol
0.00
239
2482
133
1301
1.04
0.10
5.0
3.9
2.1
2.0
ug/l
0.20
119
1166
29
273
1.07
0.08
1.4
1.4
—
—
—
0
0
10
88
1.14
0.08
1.3
1.4
—
—
—
0
0
50
520
0.95
0.08
1.2
1.3
0.6
2.0
u/ml
2.16
11
146
21
225
0.93
0.07
1.4
1.8
—
—
—
0
0
75
730
1.04
0.07
2.8
2.7
0.6
0.7
ug/l
0.77
59
476
8
93
0.86
0.07
2.3
1.7
39.1
43.4
nmol/l
—
8
88
15
159
0.94
0.03
1.1
1.2
23.6
105.0
iu/ml
—
5
62
0
9
0.00
0.00
0.0
1.0
—
1479.3
—
0
9
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
1.0
1.1
—
54.7
—
0
5
5
55
0.91
0.00
1.4
1.4
—
—
—
0
0
5
58
0.86
0.00
1.0
1.7
343.6
258.3
mu/l
—
5
52
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_LIPOSARCOMA_EXALLC – Liposarcoma, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).